Q32 Bio (QTTB) Interest Expenses (2017 - 2026)

Q32 Bio's Interest Expenses history runs 10 years deep, the most recent figure standing at $8.4 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 644.22% year-over-year to $8.4 million in Q1 2026; TTM through Mar 2026 was $8.4 million, a 644.22% increase from a year earlier, with the FY2025 full-year figure at $7.1 million, down 93.39% from the prior year.
• Interest Expenses rose to $8.4 million in Q1 2026 per QTTB's latest filing, from $200000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $179.7 million in Q4 2022 and bottomed at $200000.0 in Q4 2025.
• The 5-year median for Interest Expenses is $7.6 million (2025), against an average of $25.2 million.
• Across the five-year window, Interest Expenses slumped 99.46% in 2023 and jumped 12774.59% in 2024, its largest moves.
• Year by year, Interest Expenses stood at $179.7 million in 2022, then slumped by 97.77% to $4.0 million in 2023, then plunged by 90.0% to $400000.0 in 2024, then sank by 50.0% to $200000.0 in 2025, then soared by 4082.5% to $8.4 million in 2026.
• Per Business Quant, the three latest QTTB Interest Expenses figures stand at $8.4 million (Q1 2026), $200000.0 (Q4 2025), and $1.1 million (Q3 2025).